<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31852800</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>523</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eaav5264</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.aav5264</ELocationID><Abstract><AbstractText>Motor neuron-specific microRNA-218 (miR-218) has recently received attention because of its roles in mouse development. However, miR-218 relevance to human motor neuron disease was not yet explored. Here, we demonstrate by neuropathology that miR-218 is abundant in healthy human motor neurons. However, in amyotrophic lateral sclerosis (ALS) motor neurons, miR-218 is down-regulated and its mRNA targets are reciprocally up-regulated (derepressed). We further identify the potassium channel <i>Kv10.1</i> as a new miR-218 direct target that controls neuronal activity. In addition, we screened thousands of ALS genomes and identified six rare variants in the human miR-218-2 sequence. miR-218 gene variants fail to regulate neuron activity, suggesting the importance of this small endogenous RNA for neuronal robustness. The underlying mechanisms involve inhibition of miR-218 biogenesis and reduced processing by DICER. Therefore, miR-218 activity in motor neurons may be susceptible to failure in human ALS, suggesting that miR-218 may be a potential therapeutic target in motor neuron disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reichenstein</LastName><ForeName>Irit</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0073-9182</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eitan</LastName><ForeName>Chen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6952-0336</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz-Garcia</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4536-0523</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, UC San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haim</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magen</LastName><ForeName>Iddo</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-3011-3175</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siany</LastName><ForeName>Aviad</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1689-8698</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoye</LastName><ForeName>Mariah L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-3430-2782</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivkin</LastName><ForeName>Natali</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olender</LastName><ForeName>Tsviya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4194-6420</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toth</LastName><ForeName>Beata</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6124-3028</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravid</LastName><ForeName>Revital</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1309-7142</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandelbaum</LastName><ForeName>Amitai D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0001-6860-8491</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanowski</LastName><ForeName>Eran</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0234-7476</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0480-0390</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rymer</LastName><ForeName>Jeffrey K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0003-3630-069X</Identifier><AffiliationInfo><Affiliation>Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Rivka</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3781-2593</Identifier><AffiliationInfo><Affiliation>Department of Neurobiology, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beck</LastName><ForeName>Gilad</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4290-1360</Identifier><AffiliationInfo><Affiliation>Stem Cell Core and Advanced Cell Technologies Unit, Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ainbinder</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4747-445X</Identifier><AffiliationInfo><Affiliation>Stem Cell Core and Advanced Cell Technologies Unit, Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farhan</LastName><ForeName>Sali M K</ForeName><Initials>SMK</Initials><Identifier Source="ORCID">0000-0001-5936-0957</Identifier><AffiliationInfo><Affiliation>Analytic and Translational Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lennox</LastName><ForeName>Kimberly A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0002-5084-3482</Identifier><AffiliationInfo><Affiliation>Integrated DNA Technologies, 1710 Commercial Park, Coralville, IA 52241, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bode</LastName><ForeName>Nicole M</ForeName><Initials>NM</Initials><Identifier Source="ORCID">0000-0001-7209-303X</Identifier><AffiliationInfo><Affiliation>Integrated DNA Technologies, 1710 Commercial Park, Coralville, IA 52241, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behlke</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-4218-857X</Identifier><AffiliationInfo><Affiliation>Integrated DNA Technologies, 1710 Commercial Park, Coralville, IA 52241, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf6;ller</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3671-5684</Identifier><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saxena</LastName><ForeName>Smita</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4574-4591</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Inselspital University Hospital, University of Bern, Freiburgstrasse 16, CH-3010 Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for BioMedical Research, University of Bern, Murtenstrasse 40, CH-3008 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Cristiane A M</ForeName><Initials>CAM</Initials><Identifier Source="ORCID">0000-0002-5867-6359</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Columbia University, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costaguta</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gene Expression Laboratory and the Howard Hughes Medical Institute, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Eijk</LastName><ForeName>Kristel R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, 3584 CG, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phatnani</LastName><ForeName>Hemali</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6571-3891</Identifier><AffiliationInfo><Affiliation>Center for Genomics of Neurodegenerative Disease (CGND) and New York Genome Center (NYGC) ALS Consortium, New York, NY 10013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4924-7712</Identifier><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute and United Kingdom Dementia Research Institute, Department of Basic and Clinical Neuroscience, Department of Neurology, King's College London, London SE5 9RX, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, King's College Hospital, London SE5 9RS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba&#x15f;ak</LastName><ForeName>A Nazli</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ko&#xe7; University Translational Medicine Research Center, NDAL, Istanbul 34010, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0002-6559-3965</Identifier><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, 3584 CG, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardiman</LastName><ForeName>Orla</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-2610-1291</Identifier><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academic Unit of Neurology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin 2, Republic of Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Beaumont Hospital, Dublin 2, Republic of Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landers</LastName><ForeName>John E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0001-8084-5043</Identifier><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora</LastName><ForeName>Jesus S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0001-6633-5354</Identifier><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ALS Unit, Hospital San Rafael, Madrid 28016, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Karen E</ForeName><Initials>KE</Initials><Identifier Source="ORCID">0000-0003-0216-5717</Identifier><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-8925-2567</Identifier><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldink</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5572-9657</Identifier><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, 3584 CG, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Samuel L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-2142-166X</Identifier><AffiliationInfo><Affiliation>Gene Expression Laboratory and the Howard Hughes Medical Institute, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yizhar</LastName><ForeName>Ofer</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Weizmann Institute of Science, Rehovot 7610001, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gross</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6057-2527</Identifier><AffiliationInfo><Affiliation>Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravits</LastName><ForeName>John M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-6521-4649</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, UC San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harms</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0002-3395-1633</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Columbia University, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0002-3424-5511</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hornstein</LastName><ForeName>Eran</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5534-1924</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel. eran.hornstein@weizmann.ac.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Project MinE ALS Sequencing Consortium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 NS092340</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 NS073873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS111990</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS073873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TURNER/OCT15/972-797</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS078398</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS104022</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/L501529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS092705</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>G0600974</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051638">Ether-A-Go-Go Potassium Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C496884">KCNH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C547471">MIRN218 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051638" MajorTopicYN="N">Ether-A-Go-Go Potassium Channels</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069338" MajorTopicYN="N">Neuropathology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31852800</ArticleId><ArticleId IdType="mid">NIHMS1559095</ArticleId><ArticleId IdType="pmc">PMC7057809</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.aav5264</ArticleId><ArticleId IdType="pii">11/523/eaav5264</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amin ND, Bai G, Klug JR, Bonanomi D, Pankratz MT, Gifford WD, Hinckley CA, Sternfeld MJ, Driscoll SP, Dominguez B, Lee KF, Jin X, Pfaff SL, Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure. Science 350, 1525&#x2013;1529 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913787</ArticleId><ArticleId IdType="pubmed">26680198</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiebes KP, Nam H, Cambronne XA, Shen R, Glasgow SM, Cho HH, Kwon JS, Goodman RH, Lee JW, Lee S, Lee SK, miR-218 is essential to establish motor neuron fate as a downstream effector of Isl1-Lhx3. Nat Commun 6, 7718 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4518464</ArticleId><ArticleId IdType="pubmed">26212498</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A, Eitan C, Liou LL, Libby RT, Rivkin N, Magen I, Reichenstein I, Oppenheim H, Eilam R, Silvestroni A, Alajajian B, Ben-Dov IZ, Aebischer J, Savidor A, Levin Y, Sons R, Hammond SM, Ravits JM, Moller T, Hornstein E, Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. The EMBO journal 34, 2633&#x2013;2651 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoye ML, Koval ED, Wegener AJ, Hyman TS, Yang C, O'Brien DR, Miller RL, Cole T, Schoch KM, Shen T, Kunikata T, Richard JP, Gutmann DH, Maragakis NJ, Kordasiewicz HB, Dougherty JD, Miller TM, MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models. J Neurosci 37, 5574&#x2013;5586 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5452343</ArticleId><ArticleId IdType="pubmed">28416596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoye ML, Regan MR, Jensen LA, Lake AM, Reddy LV, Vidensky S, Richard JP, Maragakis NJ, Rothstein JD, Dougherty JD, Miller TM, Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis. Brain, (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6113638</ArticleId><ArticleId IdType="pubmed">30007309</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ, State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17, 17&#x2013;23 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J, Allred P, Bali T, Pestronk A, Goate A, Miller TM, Mitra RD, Ravits J, Harms MB, Baloh RH, Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol 77, 100&#x2013;113 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4293318</ArticleId><ArticleId IdType="pubmed">25382069</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A, Amyotrophic Lateral Sclerosis. N Engl J Med 377, 162&#x2013;172 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, van den Berg LH, Veldink J, Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol 13, 96&#x2013;104 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, van Rheenen W, van Eijk KR, Jones AR, Keagle P, Shatunov A, Sproviero W, Smith BN, van Es MA, Topp SD, Kenna A, Miller JW, Fallini C, Tiloca C, McLaughlin RL, Vance C, Troakes C, Colombrita C, Mora G, Calvo A, Verde F, Al-Sarraj S, King A, Calini D, de Belleroche J, Baas F, van der Kooi AJ, de Visser M, Ten Asbroek AL, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Munoz-Blanco JL, Strom TM, Meitinger T, Morrison KE, Consortium S, Lauria G, Williams KL, Leigh PN, Nicholson GA, Blair IP, Leblond CS, Dion PA, Rouleau GA, Pall H, Shaw PJ, Turner MR, Talbot K, Taroni F, Boylan KB, Van Blitterswijk M, Rademakers R, Esteban-Perez J, Garcia-Redondo A, Van Damme P, Robberecht W, Chio A, Gellera C, Drepper C, Sendtner M, Ratti A, Glass JD, Mora JS, Basak NA, Hardiman O, Ludolph AC, Andersen PM, Weishaupt JH, Brown RH Jr., Al-Chalabi A, Silani V, Shaw CE, van den Berg LH, Veldink JH, Landers JE, NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet 48, 1037&#x2013;1042 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr., Cleveland DW, Decoding ALS: from genes to mechanism. Nature 539, 197&#x2013;206 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N, McGlinn E, Heiser PW, Wills AM, Wirguin I, Rubin LL, Misawa H, Tabin CJ, Brown R Jr., Chen A, Hornstein E, miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A 107, 13111&#x2013;13116 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919953</ArticleId><ArticleId IdType="pubmed">20616011</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, Chau BN, Wu GF, Miller TM, Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet 22, 4127&#x2013;4135 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3781640</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodall EF, Heath PR, Bandmann O, Kirby J, Shaw PJ, Neuronal dark matter: the emerging role of microRNAs in neurodegeneration. Front Cell Neurosci 7, 178 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3794211</ArticleId><ArticleId IdType="pubmed">24133413</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D, Droppelmann CA, He Z, Volkening K, Strong MJ, Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels. Mol Brain 6, 26 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitan C, Hornstein E, Vulnerability of microRNA biogenesis in FTD-ALS. Brain Res, (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26778173</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, Hur J, Lunn JS, Paez-Colasante X, Bender DE, Yung R, Sakowski SA, Feldman EL, Expression of microRNAs in human postmortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol Cell Neurosci 71, 34&#x2013;45 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung YT, Peng KC, Chen YC, Yen YP, Chang M, Thams S, Chen JA, Mir-17 approximately 92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration. Cell Stem Cell, (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31155482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ, Han S, Peng T, Thams S, Mikkilineni S, Mellin C, Merkle FT, Davis-Dusenbery BN, Ziller M, Oakley D, Ichida J, Di Costanzo S, Atwater N, Maeder ML, Goodwin MJ, Nemesh J, Handsaker RE, Paull D, Noggle S, McCarroll SA, Joung JK, Woolf CJ, Brown RH, Eggan K, Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14, 781&#x2013;795 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V, Bell GW, Nam JW, Bartel DP, Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4532895</ArticleId><ArticleId IdType="pubmed">26267216</ArticleId></ArticleIdList></Reference><Reference><Citation>Krach F, Batra R, Wheeler EC, Vu AQ, Wang R, Hutt K, Rabin SJ, Baughn MW, Libby RT, Diaz-Garcia S, Stauffer J, Pirie E, Saberi S, Rodriguez M, Madrigal AA, Kohl Z, Winner B, Yeo GW, Ravits J, Transcriptome-pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol 136, 405&#x2013;423 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6215775</ArticleId><ArticleId IdType="pubmed">29881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang da W, Sherman BT, Lempicki RA, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37, 1&#x2013;13 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615629</ArticleId><ArticleId IdType="pubmed">19033363</ArticleId></ArticleIdList></Reference><Reference><Citation>Milligan C, Gifondorwa D, Isolation and culture of postnatal spinal motoneurons. Methods Mol Biol 793, 77&#x2013;85 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196523</ArticleId><ArticleId IdType="pubmed">21913094</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dongen S, Abreu-Goodger C, Enright AJ, Detecting microRNA binding and siRNA off-target effects from expression data. Nat Methods 5, 1023&#x2013;1025 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2635553</ArticleId><ArticleId IdType="pubmed">18978784</ArticleId></ArticleIdList></Reference><Reference><Citation>Das M, Molnar P, Devaraj H, Poeta M, Hickman JJ, Electrophysiological and morphological characterization of rat embryonic motoneurons in a defined system. Biotechnol Prog 19, 1756&#x2013;1761 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14656152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaalund SS, Veno MT, Bak M, Moller RS, Laursen H, Madsen F, Broholm H, Quistorff B, Uldall P, Tommerup N, Kauppinen S, Sabers A, Fluiter K, Moller LB, Nossent AY, Silahtaroglu A, Kjems J, Aronica E, Tumer Z, Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-convergence on axonal guidance. Epilepsia 55, 2017&#x2013;2027 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25410734</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M, Khudayberdiev S, Leuschner PF, Busch CJ, Kane C, Hubel K, Dekker F, Hedberg C, Rengarajan B, Drepper C, Waldmann H, Kauppinen S, Greenberg ME, Draguhn A, Rehmsmeier M, Martinez J, Schratt GM, A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 11, 705&#x2013;716 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3595613</ArticleId><ArticleId IdType="pubmed">19465924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Fernandes CC, Ewell LA, John D, Romoli B, Curia G, Taylor SR, Frady EP, Jensen AB, Liu JC, Chaabane MM, Belal C, Nathanson JL, Zoli M, Leutgeb JK, Biagini G, Yeo GW, Berg DK, MicroRNA-101 Regulates Multiple Developmental Programs to Constrain Excitation in Adult Neural Networks. Neuron 92, 1337&#x2013;1351 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5182124</ArticleId><ArticleId IdType="pubmed">27939580</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore MJ, Scheel TK, Luna JM, Park CY, Fak JJ, Nishiuchi E, Rice CM, Darnell RB, miRNA-target chimeras reveal miRNA 3'-end pairing as a major determinant of Argonaute target specificity. Nat Commun 6, 8864 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4674787</ArticleId><ArticleId IdType="pubmed">26602609</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson L, iMN (Exp 2) - ALS, SMA and Control (unaffected) iMN cell lines differentiated from iPS cell lines using a long differentiation protocol - RNA-seq. (2017).</Citation></Reference><Reference><Citation>E. A. L. S. S. C. Project Min, Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur J Hum Genet, (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, miRBase: tools for microRNA genomics. Nucleic Acids Res 36, D154&#x2013;158 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2238936</ArticleId><ArticleId IdType="pubmed">17991681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, N. G. E. S. P.-E. L. P. Team, Christiani DC, Wurfel MM, Lin X, Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet 91, 224&#x2013;237 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3415556</ArticleId><ArticleId IdType="pubmed">22863193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Teslovich TM, Boehnke M, Lin X, General framework for meta-analysis of rare variants in sequencing association studies. Am J Hum Genet 93, 42&#x2013;53 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710762</ArticleId><ArticleId IdType="pubmed">23768515</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TA, Jo MH, Choi YG, Park J, Kwon SC, Hohng S, Kim VN, Woo JS, Functional Anatomy of the Human Microprocessor. Cell 161, 1374&#x2013;1387 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26027739</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN, The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415&#x2013;419 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14508493</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbashir SM, Lendeckel W, Tuschl T, RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15, 188&#x2013;200 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC312613</ArticleId><ArticleId IdType="pubmed">11157775</ArticleId></ArticleIdList></Reference><Reference><Citation>Nykanen A, Haley B, Zamore PD, ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107, 309&#x2013;321 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11701122</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, Sawai S, Hattori T, Bostock H, Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 129, 953&#x2013;962 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16467388</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Nicholson GA, Kiernan MC, Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 131, 1540&#x2013;1550 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo JJ, Siddique T, Fu R, Heckman CJ, Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol 563, 843&#x2013;854 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1665614</ArticleId><ArticleId IdType="pubmed">15649979</ArticleId></ArticleIdList></Reference><Reference><Citation>Zona C, Pieri M, Carunchio I, Voltage-dependent sodium channels in spinal cord motor neurons display rapid recovery from fast inactivation in a mouse model of amyotrophic lateral sclerosis. J Neurophysiol 96, 3314&#x2013;3322 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16899637</ArticleId></ArticleIdList></Reference><Reference><Citation>Bories C, Amendola J, Lamotte d'Incamps B, Durand J, Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 25, 451&#x2013;459 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17284186</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieri M, Albo F, Gaetti C, Spalloni A, Bengtson CP, Longone P, Cavalcanti S, Zona C, Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett 351, 153&#x2013;156 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14623129</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B, Peuscher MH, Hynynen M, Chen A, Neve RL, Brown RH Jr., Constantine-Paton M, Bellingham MC, Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 28, 10864&#x2013;10874 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3844745</ArticleId><ArticleId IdType="pubmed">18945894</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan KA, Schuster JE, Fu R, Siddique T, Heckman CJ, Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis. J Physiol 589, 2245&#x2013;2260 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3098701</ArticleId><ArticleId IdType="pubmed">21486770</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs A, Kutterer S, Muhling T, Duda J, Schutz B, Liss B, Keller BU, Roeper J, Selective mitochondrial Ca2+ uptake deficit in disease endstage vulnerable motoneurons of the SOD1G93A mouse model of amyotrophic lateral sclerosis. J Physiol 591, 2723&#x2013;2745 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3678052</ArticleId><ArticleId IdType="pubmed">23401612</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Roselli F, Singh K, Leptien K, Julien JP, Gros-Louis F, Caroni P, Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 80, 80&#x2013;96 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin AC, Burr K, Borooah S, Foster JD, Cleary EM, Geti I, Vallier L, Shaw CE Chandran S, Miles GB, Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun 6, 5999 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338554</ArticleId><ArticleId IdType="pubmed">25580746</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Ni W, Horwich AL, Kaczmarek LK, An ALS-Associated Mutant SOD1 Rapidly Suppresses KCNT1 (Slack) Na+-Activated K+ Channels in Aplysia Neurons. J Neurosci 37, 2258&#x2013;2265 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5338764</ArticleId><ArticleId IdType="pubmed">28119399</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang YM, Yamamoto M, Kobayashi Y, Yoshihara T, Liang Y, Terao S, Takeuchi H, Ishigaki S, Katsuno M, Adachi H, Niwa J, Tanaka F, Doyu M, Yoshida M, Hashizume Y, Sobue G, Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 57, 236&#x2013;251 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15668976</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SS, Sandoe J, Perez NP, Williams LA, Lee S, Boulting G, Berry JD, Brown RH Jr., Cudkowicz ME, Bean BP, Eggan K, Woolf CJ, Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep 7, 1&#x2013;11 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujock M, Stanslowsky N, Bufler S, Naumann M, Reinhardt P, Sterneckert J, Kefalakes E, Kassebaum C, Bursch F, Lojewski X, Storch A, Frickenhaus M, Boeckers TM, Putz S, Demestre M, Liebau S, Klingenstein M, Ludolph AC, Dengler R, Kim KS, Hermann A, Wegner F, Petri S, 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells. Stem Cells 34, 1563&#x2013;1575 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26946488</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma P, Augustine GJ, Ammar MR, Tashiro A, Cohen SM, A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity. Nat Neurosci 18, 379&#x2013;385 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25643297</ArticleId></ArticleIdList></Reference><Reference><Citation>Guven-Ozkan T, Busto GU, Schutte SS, Cervantes-Sandoval I, O'Dowd DK, Davis RL, MiR-980 Is a Memory Suppressor MicroRNA that Regulates the Autism-Susceptibility Gene A2bp1. Cell Rep 14, 1698&#x2013;1709 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5103286</ArticleId><ArticleId IdType="pubmed">26876166</ArticleId></ArticleIdList></Reference><Reference><Citation>Harraz MM, Eacker SM, Wang X, Dawson TM, Dawson VL, MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc Natl Acad Sci U S A 109, 18962&#x2013;18967 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3503176</ArticleId><ArticleId IdType="pubmed">23112146</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CL, Plotkin JL, Veno MT, von Schimmelmann M, Feinberg P, Mann S, Handler A, Kjems J, Surmeier DJ, O'Carroll D, Greengard P, Schaefer A, MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science 342, 1254&#x2013;1258 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932786</ArticleId><ArticleId IdType="pubmed">24311694</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakai A, Saitow F, Miyake N, Miyake K, Shimada T, Suzuki H, miR-7a alleviates the maintenance of neuropathic pain through regulation of neuronal excitability. Brain 136, 2738&#x2013;2750 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23861446</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore R, Rajman M, Schwale C, Bicker S, Antoniou A, Bruehl C, Draguhn A, Schratt G, MiR-134-dependent regulation of Pumilio-2 is necessary for homeostatic synaptic depression. The EMBO journal 33, 2231&#x2013;2246 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4282509</ArticleId><ArticleId IdType="pubmed">25097251</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross C, Yao X, Engel T, Tiwari D, Xing L, Rowley S, Danielson SW, Thomas KT, Jimenez-Mateos EM, Schroeder LM, Pun RY, Danzer SC, Henshall DC, Bassell GJ, MicroRNA-Mediated Downregulation of the Potassium Channel Kv4.2 Contributes to Seizure Onset. Cell Rep 17, 37&#x2013;45 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5061042</ArticleId><ArticleId IdType="pubmed">27681419</ArticleId></ArticleIdList></Reference><Reference><Citation>Raczy C, Petrovski R, Saunders CT, Chorny I, Kruglyak S, Margulies EH, Chuang HY, Kallberg M, Kumar SA, Liao A, Little KM, Stromberg MP, Tanner SW, Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms. Bioinformatics 29, 2041&#x2013;2043 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23736529</ArticleId></ArticleIdList></Reference><Reference><Citation>Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, Handsaker RE, Lunter G, Marth GT, Sherry ST, McVean G, Durbin R, Genomes Project Analysis G, The variant call format and VCFtools. Bioinformatics 27, 2156&#x2013;2158 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137218</ArticleId><ArticleId IdType="pubmed">21653522</ArticleId></ArticleIdList></Reference><Reference><Citation>Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen WM, Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867&#x2013;2873 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025716</ArticleId><ArticleId IdType="pubmed">20926424</ArticleId></ArticleIdList></Reference><Reference><Citation>Rungta RL, Choi HB, Lin PJ, Ko RW, Ashby D, Nair J, Manoharan M, Cullis PR, Macvicar BA, Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain. Mol Ther Nucleic Acids 2, e136 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3889191</ArticleId><ArticleId IdType="pubmed">24301867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gage GJ, Kipke DR, Shain W, Whole animal perfusion fixation for rodents. Journal of visualized experiments : JoVE, (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3476408</ArticleId><ArticleId IdType="pubmed">22871843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuovo GJ, In situ detection of precursor and mature microRNAs in paraffin embedded, formalin fixed tissues and cell preparations. Methods 44, 39&#x2013;46 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18158131</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena JT, Sohn-Lee C, Rouhanifard SH, Ludwig J, Hafner M, Mihailovic A, Lim C, Holoch D, Berninger P, Zavolan M, Tuschl T, miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat Methods 6, 139&#x2013;141 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838186</ArticleId><ArticleId IdType="pubmed">19137005</ArticleId></ArticleIdList></Reference><Reference><Citation>Obernosterer G, Martinez J, Alenius M, Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat Protoc 2, 1508&#x2013;1514 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17571058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, Jung S, Amit I, Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159, 1312&#x2013;1326 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437213</ArticleId><ArticleId IdType="pubmed">25480296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14, R36 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053844</ArticleId><ArticleId IdType="pubmed">23618408</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Pyl PT, Huber W, HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166&#x2013;169 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>